NCT01218022View on ClinicalTrials.gov

Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Healthy
Interventions
DRUG

Losartan Potassium Tablets

Trial Locations (1)

382 428

Torrent BE Centre, Gandhinagar

All Listed Sponsors
lead

Torrent Pharmaceuticals Limited

INDUSTRY

NCT01218022 - Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fasting Condition | Biotech Hunter | Biotech Hunter